LEADER 04668nam 2201201z- 450 001 9910557142003321 005 20231214133100.0 035 $a(CKB)5400000000040638 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68385 035 $a(EXLCZ)995400000000040638 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (240 p.) 311 $a3-03943-685-6 311 $a3-03943-686-4 330 $aAfter our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer. 606 $aMedicine$2bicssc 610 $aMetallothionein 610 $aurothelium 610 $aurothelial cancer 610 $acadmium exposure 610 $azinc transporter 610 $abladder 610 $aTAGLN 610 $aF-actin 610 $aPTEN 610 $ap53 610 $atumorigenesis 610 $aproliferation 610 $ainvasion 610 $aTERT promoter mutations 610 $aFGFR3 610 $anon muscle invasive bladder cancer 610 $aBCG therapy 610 $abladder cancer 610 $aJAK-STAT pathway 610 $acombination therapy 610 $aoncolytic adenovirus 610 $avirotherapy 610 $aSTAT3/5 inhibitor 610 $aJAK inhibitor 610 $aXVir-N-31 610 $abladder cancer detection 610 $aurinary biomarkers 610 $aDNA methylation 610 $aECRG4 610 $aITIH5 610 $abiomarker 610 $acancer 610 $agrade 610 $ametabolomics 610 $aMS 610 $aNMR 610 $abiomarkers 610 $atumor markers 610 $aprognosis 610 $aheparanase 610 $asyndecan-1 610 $aheparan sulfate proteoglycans (HSPGs) 610 $aurothelial carcinoma 610 $amiRNA 610 $aquantitative PCR 610 $atumor marker 610 $avoided urine cytology 610 $aKDM7A 610 $ahistone demethylase 610 $aTC-E 5002 610 $aandrogen receptor 610 $adrug resistance 610 $anon-invasive detection 610 $atelomerase 610 $asomatic mutations 610 $aTERT promoter region 610 $amuscle-invasive bladder cancer 610 $achemotherapy 610 $aimmunotherapy 610 $apersonalized medicine 610 $apredictive biomarker 610 $asurvivin 610 $aBIRC5 610 $amacrophage 610 $aKRT20 610 $aERBB2 610 $aMIBC 610 $aprediction 610 $aRT-qPCR 610 $aadjuvant chemotherapy 610 $asurvival 615 7$aMedicine 700 $aEcke$b Thorsten$4edt$01313317 702 $aOtto$b Thomas$4edt 702 $aEcke$b Thorsten$4oth 702 $aOtto$b Thomas$4oth 906 $aBOOK 912 $a9910557142003321 996 $aDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer ? Illumination of a Vision 2.0$93031280 997 $aUNINA